Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues and problems before us

J S Parker

    Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
    |March 12, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers.

    ESMO open·2025
    Same author

    Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.

    ESMO open·2025
    Same author

    TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer.

    ESMO open·2024
    Same author

    Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B).

    ESMO open·2024
    Same author

    Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2023